Skip to content

GERIAMED

Active
Private limited company (pre-2019)founded 20187 yrs activePotaardestraat 138, 1082 Sint-Agatha-Berchem, BelgiumKBO/BCE: BE 0716.635.505
Summary

GERIAMED has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€19,845) and a net result of -€34,854. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 18230 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (very low).

Risk analysisWatch ReportCompare
GERIAMEDActiveChecked score 44/100
Risk analysis ReportCompare

Overview

What they do
Specialist medical practice
NACE 86220
1 site
How big
€50,135total assets 2025
Equity
-€19,845
Loss
-€34,854
Turnover not published (abridged schema)
Financially healthy?
44 Weak Checked score 2025
Bankruptcy chance 12 m
0.5%
Who decides
Accounts 23 d early0 of 1 deed read
Why 44- Limited track record- Higher-failure-rate region- Annual accounts: weaker financial profile- Negative equity+ Lower-failure-rate sectorLatest accounts filed on timeShow the evidence

Checked score

Score 2025
44 / 100
Weak
Negative equity caps the score. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0▼-100
Solvency0▼-100
Growth32▼-46
Track record100
Bankruptcy probability, 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity ample (current ratio 4.2 against 4.1 in 2024; short-term debt: 23.5% and cash: 33.6% of total assets), but equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 7 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-39.6%
Return on assets
-69.5%
Age of the figures
9 mo
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
19202122232425
2019 to 2025 · latest year -€19,845
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
23 d early
2024
28 d early
2023
69 d late
2022
on the day
2021
31 d late
2020
on the day
2019
15 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 5 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 31 July (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Weakest financial yearnet -€34,854
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Risk: Negative equityfiscal year 2025: debts exceed assets -€19,845 View
  • Caution: From profit to loss in 2025after €27,270 in 2024 -€34,854 View
  • Caution: Among the weakest 5% on solvencysector median 63.8% · 18,230 companies -39.6% View

By topic

Financials

Fiscal year
2025
Total assets
€50,135
Loss
-€34,854
Solvency
-39.6%
Total assets▼ 28.1%
Net result
20192025
Go to Financials

Timeline

Events
12
Since
2020
Next accounts
by 31-07-2027
  1. 08-07-2026Annual accounts filed
  2. 31-12-2025Weakest financial year
  3. 03-07-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Specialist medical practiceNACE 86220
Founded
19-12-2018
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure